Lenvatinib for Anaplastic Thyroid Cancer

BACKGROUND: Lenvatinib has been approved by regulatory agencies in Japan, the United States, and the European Union for treatment of radioiodine-refractory differentiated thyroid cancer (RR-DTC). Thyroid cancer, however, is a clinically diverse disease that includes anaplastic thyroid cancer (ATC),...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahara, Makoto, Kiyota, Naomi, Yamazaki, Tomoko, Chayahara, Naoko, Nakano, Kenji, Inagaki, Lina, Toda, Kazuhisa, Enokida, Tomohiro, Minami, Hironobu, Imamura, Yoshinori, Sasaki, Tatsuya, Suzuki, Takuya, Fujino, Katsuki, Dutcus, Corina E., Takahashi, Shunji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331066/
https://www.ncbi.nlm.nih.gov/pubmed/28299283
http://dx.doi.org/10.3389/fonc.2017.00025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331066/
https://www.ncbi.nlm.nih.gov/pubmed/28299283
http://dx.doi.org/10.3389/fonc.2017.00025

Ejemplares similares